TKTL1 and neoplasm: Transketolase-like 1 (TKTL1) is elevated in a variety of different tumour entities and has been correlated to tumour stage, aggressive behaviour, invasive growth, therapeutic resistance, and poor prognosis [9, 13, 16–29].